Business Context and Reporting Period
Boxlight Corporation filed this Form 8-K on October 6, 2026, concerning transactions and security-rights changes dated September 30, 2026, with a Series D holder consent dated October 6. The filing reports financing and corporate actions, not operating results for a quarterly or annual period.
Financing and Key Financial Information
- Series E private placement: Boxlight agreed to issue 106,250 shares of Series E Convertible Preferred Stock to J.J. Astor & Co. for $850,000, or $8 per share. The shares have an aggregate stated value of $1,062,500 ($10 per share), reflecting a 20% original issue discount.
- Use of proceeds: General corporate purposes, including working capital and potential acquisitions. Proceeds may not be used to repay indebtedness other than ordinary-course trade payables, redeem equity, or settle pending or threatened litigation.
- Prior Series D financing: The filing recaps an August 2026 agreement to sell 937,500 Series D shares for $7.5 million, with aggregate stated value of $9.375 million. The filing does not provide updated cash, debt, revenue, profit, cash-flow, margin, or liquidity figures.
Material Changes and Security Terms
- Series E conversion and dilution: Conversion price is generally the greater of an adjusted floor and 80% of the lowest closing share price in the preceding five trading days. The initial floor is $0.95 and may reset downward; certain issuances can trigger a full-ratchet adjustment. These terms may materially dilute common shareholders.
- Conversion limits and seniority: Series E ranks below Series D and senior secured debt, but ahead of common stock and other junior securities. A 19.99% exchange cap applies until required Nasdaq stockholder approvals are obtained; beneficial ownership and voting limits also apply. The company must seek required stockholder approvals at a meeting within 180 days of initial issuance and every 30 days thereafter until obtained.
- Dividends and defaults: There are no regular dividends. Certain trigger events can cause cumulative dividends at 20% annually, payable in kind. Events of default can increase stated value by a 20% default premium. The Series E terms provide no cash redemption right.
- Series D rights amended: The liquidation preference is $10 per share, senior to common stock and pari passu with designated parity securities, but is no longer triggered by a merger, sale of substantially all assets, or sale of stock. Series D holders also gained approval rights over specified mergers, asset sales, tender offers, reorganizations, and transactions resulting in a change of control.
- Series D consent: A majority of Series D holders consented to the Series E issuance and waived related rights and potential defaults, without receiving consideration.
Outlook, Risks, and Unusual Items
- The Series E SPA restricts, subject to exceptions, additional equity issuance, new indebtedness, certain registration statements, and variable-rate transactions while Series E remains outstanding; the existing equity line of credit is excepted from the variable-rate restriction.
- The company must register the common shares issuable on conversion. Missed registration deadlines may result in liquidated damages of 5% of the subscription amount per specified event and each 30-day anniversary, with 18% annual interest on late payments.
- Chairman Michael Pope is also J.J. Astor’s CEO. He disclosed his interest, recused himself, and did not participate in the decision; the disinterested directors unanimously approved the transaction.
- The filing gives no operating guidance or financial forecast. The amount of net proceeds available after transaction costs is not stated.
Investor Verification Points
- Confirm whether the $850,000 subscription was funded and the Series E shares issued, and review the company’s subsequent cash and liquidity disclosures.
- Review the complete Series E certificate and purchase documents for conversion-price resets, default triggers, share-reserve requirements, and registration deadlines.
- Track the required Nasdaq stockholder approvals and any resulting change to the exchange cap or voting limits.
- Assess potential dilution under the variable conversion formula and the effects of the amended Series D liquidation and transaction-consent rights.
- Review subsequent filings for registration effectiveness, liquidated damages, use of proceeds, and any exercise of the existing equity line of credit.